Evidence map›Paper›PMID 29254494›Full record

ReviewGenome medicine2017

Mapping genetic variations to three-dimensional protein structures to enhance variant interpretation: a proposed framework.

Gustavo Glusman, Peter W Rose, Andreas Prlić, Jennifer Dougherty, José M Duarte, Andrew S Hoffman, Geoffrey J Barton, Emøke Bendixen, Timothy Bergquist, Christian Bock and 27 more

Abstract readReview
In one paragraph

Review in Genome medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Cancer-associated TRF1 mutations alter PARP1 interaction dynamics: an in silico study.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Gustavo GlusmanInstitute for Systems Biology, Seattle, WA, 98109, USA. Gustavo@SystemsBiology.org.ORCID http://orcid.org/0000-0001-8060-5955
Peter W RoseSan Diego Supercomputer Center, University of California San Diego, La Jolla, CA, 98093, USA.
Andreas PrlićSan Diego Supercomputer Center, University of California San Diego, La Jolla, CA, 98093, USA.
Jennifer DoughertyInstitute for Systems Biology, Seattle, WA, 98109, USA.
José M DuarteRCSB Protein Data Bank, University of California San Diego, La Jolla, CA, 98093, USA.
Andrew S HoffmanHuman Centered Design & Engineering, University of Washington, Seattle, WA, 98195, USA.
Geoffrey J BartonDivision of Computational Biology, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK.
Emøke BendixenDepartment of Molecular Biology and Genetics, Aarhus University, 8000, Aarhus, Denmark.
Timothy BergquistDepartment of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, 98109, USA.
Christian BockDepartment of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, 98109, USA.
Elizabeth BrunkUniversity of California San Diego, La Jolla, CA, 92093, USA.
Marija BuljanInstitute of Molecular Systems Biology, ETH Zurich, CH-8093, Zurich, Switzerland.
Stephen K BurleySan Diego Supercomputer Center, University of California San Diego, La Jolla, CA, 98093, USA.
Binghuang CaiDepartment of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, 98109, USA.
Hannah CarterUniversity of California San Diego, La Jolla, CA, 92093, USA.
JianJiong GaoKravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Adam GodzikSBP Medical Discovery Institute, La Jolla, CA, 92037, USA.
Michael HeuerAMPLab, University of California, Berkeley, CA, 94720, USA.ORCID http://orcid.org/0000-0002-9052-6000
Michael HicksHuman Longevity, Inc, San Diego, CA, 92121, USA.
Thomas HrabeSBP Medical Discovery Institute, La Jolla, CA, 92037, USA.
Rachel KarchinDepartment of Biomedical Engineering, Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD, 21218, USA.
Julia Koehler LemanFlatiron Institute, Center for Computational Biology, Simons Foundation, New York, NY, 10010, USA.
Lydie LaneSIB Swiss Institute of Bioinformatics and University of Geneva, CH-1211, Geneva, Switzerland.
David L MasicaDepartment of Biomedical Engineering, Institute for Computational Medicine, Johns Hopkins University, Baltimore, MD, 21218, USA.
Sean D MooneyDepartment of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, 98109, USA.
John MoultInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, 20850, USA.
Gilbert S OmennInstitute for Systems Biology, Seattle, WA, 98109, USA.
Frances PearlSchool of Life Sciences, University of Sussex, Brighton, BN1 9QG, UK.
Vikas PejaverDepartment of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, 98109, USA.
Sheila M ReynoldsInstitute for Systems Biology, Seattle, WA, 98109, USA.
Ariel RokemThe University of Washington eScience Institute, Seattle, WA, 98195, USA.
Torsten SchwedeSIB Swiss Institute of Bioinformatics and Biozentrum University of Basel, CH-4056, Basel, Switzerland.
Sicheng SongDepartment of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, 98109, USA.
Hagen TilgnerBrain and Mind Research Institute, Weill Cornell Medicine, New York City, NY, 10021, USA.
Yana ValasatavaRCSB Protein Data Bank, University of California San Diego, La Jolla, CA, 98093, USA.
Yang ZhangDepartment of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI, 48109-2218, USA.
Eric W DeutschInstitute for Systems Biology, Seattle, WA, 98109, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Training SubprojectU54HG007990 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H, PATTERSON, DAVID · 2014 to 2018
$14.8M
Biomedical Data Translator Technical Feasibility Assessment and Architecture DesignOT3TR002026 · NCATS · INSTITUTE FOR SYSTEMS BIOLOGY · PI GLUSMAN, GWÊNLYN, HUANG, SUI · 2016 to 2019
$3.3M
Informatics Tools for High-throughput Analysis of Cancer MutationsU24CA204817 · NCI · JOHNS HOPKINS UNIVERSITY · PI KARCHIN, RACHEL · 2016 to 2020
$2.5M
Biotechnology and Biological Sciences Research Council BB/G022682/1Biotechnology and Biological Sciences Research Council BB/J019364/1Biotechnology and Biological Sciences Research Council BB/L020742/1National Science Foundation IIS-1636804National Science Foundation IIS-1636903NCATS NIH HHS OT3 TR002026NCATS NIH HHS OT3TR002026NCI NIH HHS P30 CA008748NCI NIH HHS P30-CA008748NCI NIH HHS U24 CA204817NHGRI NIH HHS U54 HG007990
6 · The paper itself

Abstract

The translation of personal genomics to precision medicine depends on the accurate interpretation of the multitude of genetic variants observed for each individual. However, even when genetic variants are predicted to modify a protein, their functional implications may be unclear. Many diseases are caused by genetic variants affecting important protein features, such as enzyme active sites or interaction interfaces. The scientific community has catalogued millions of genetic variants in genomic databases and thousands of protein structures in the Protein Data Bank. Mapping mutations onto three-dimensional (3D) structures enables atomic-level analyses of protein positions that may be important for the stability or formation of interactions; these may explain the effect of mutations and in some cases even open a path for targeted drug development. To accelerate progress in the integration of these data types, we held a two-day Gene Variation to 3D (GVto3D) workshop to report on the latest advances and to discuss unmet needs. The overarching goal of the workshop was to address the question: what can be done together as a community to advance the integration of genetic variants and 3D protein structures that could not be done by a single investigator or laboratory? Here we describe the workshop outcomes, review the state of the field, and propose the development of a framework with which to promote progress in this arena. The framework will include a set of standard formats, common ontologies, a common application programming interface to enable interoperation of the resources, and a Tool Registry to make it easy to find and apply the tools to specific analysis problems. Interoperability will enable integration of diverse data sources and tools and collaborative development of variant effect prediction methods.

Indexed as

Polymorphism, GeneticProtein ConformationAlgorithmsCongresses as TopicGenome-Wide Association StudyHumansSequence Analysis, Protein

Identifiers

PMID29254494
PMCPMC5735928

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.